NEW YORK, March 5, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding
LyondellBasell Industries NV (NYSE: LYB), Westlake Chemical Corp.
(NYSE: WLK), Flotek Industries Inc. (NYSE: FTK), Cabot Corp. (NYSE:
CBT), and Sensient Technologies Corporation (NYSE: SXT). Private
wealth members receive these notes ahead of publication. To reserve
complementary membership, limited openings are available at:
http://www.AnalystsReview.com/register
LyondellBasell Industries NV Analyst
Notes
On February 20, 2014,
LyondellBasell Industries NV (LyondellBasell) announced that its
Board of Directors has authorized and declared an interim dividend
of $0.60 per share. The interim
dividend is payable on March 17,
2014, to shareholders of record on March 3, 2014, with an ex-dividend date of
February 27, 2014. The full analyst
notes on LyondellBasell Industries NV are available to download
free of charge at:
http://www.AnalystsReview.com/03052014/LYB/report.pdf
--
Westlake Chemical Corp. Analyst
Notes
On February 18, 2014, Westlake
Chemical Corp. (Westlake) announced that its Board of Directors has
declared a two-for-one split of the Company's common stock. The
Company also announced an increase in the quarterly cash dividend
on the Company's common stock to $0.252 per share, representing 12% growth on a
pre-split basis. "These actions reflect the financial strength of
the company," said Albert Chao,
President and CEO. "The cash dividend increase, the second in less
than a year, and the stock split demonstrates the Board's continued
confidence in our ability to deliver strong earnings." The
two-for-one common stock split will be accomplished by means of a
stock dividend, to be distributed on March
18, 2014 to stockholders of record as of February 28, 2014. The cash dividend is payable
on March 18, 2014 to stockholders of
record as of February 28, 2014, and
will be paid on the pre-split shares. The full analyst notes on
Westlake Chemical Corp. are available to download free of charge
at:
http://www.AnalystsReview.com/03052014/WLK/report.pdf
--
Flotek Industries Inc. Analyst
Notes
On February 11, 2014, Flotek
Industries Inc. (Flotek) announced that it has entered into a
Letter of Intent (LOI) to acquire Plano,
Texas based SiteLark, LLC (SiteLark). Flotek will provide
total initial consideration of $0.6
million in cash and Flotek common stock for SiteLark,
subject to completion of due diligence and certain adjustments.
"The addition of Dee and the SiteLark team to the Flotek family is
another key step in our quest to build a best-in-class EOR practice
focused on offering key services from initial modeling of projects
to evaluation and adjustment of those projects," said John Chisholm, Chairman, President and CEO of
Flotek. Upon the completion of due diligence and other
requirements, Flotek expects to close on the SiteLark acquisition
by March 31, 2014. The full analyst
notes on Flotek Industries Inc. are available to download free of
charge at:
http://www.AnalystsReview.com/03052014/FTK/report.pdf
--
Cabot Corp. Analyst Notes
On February 24, 2014, Cabot Corp.
(Cabot) announced that it has entered into a contract to provide
its DARCO® Hg family of activated carbon products to a Northern US
power generator. The contract is valued at up to $6 million and will allow the utility to meet
stringent federal regulations for mercury emissions in the US.
Under the terms of the contract, Cabot will supply DARCO Hg-LH and
DARCO Hg-LH Extra powdered activated carbon to satisfy 100% of the
utility's requirements across its four boilers at three generating
stations. Bart Kalkstein, Vice
President and General Manager, Global Emission Control
Technologies, Cabot Purification Solutions, said, "We are
continuing to win contracts like this as mercury-emitting utilities
look to use activated carbon to meet these requirements and seek an
experienced and technically advanced partner as their supplier.
Moreover, our robust supply chain and secure source of supply will
ensure that we can fulfill our customers' needs as market demand
increases - distinguishing us from the competition." The full
analyst notes on Cabot Corp. are available to download free of
charge at:
http://www.AnalystsReview.com/03052014/CBT/report.pdf
--
Sensient Technologies Corporation
Analyst Notes
On March 3, 2014, Sensient
Technologies Corp.'s (Sensient) stock rose 0.59% to end the day at
$52.74, compared to the previous
day's closing price at $52.43. The
Company's stock increased 0.25% over the past three trading days,
compared to the Dow Jones Industrial Average which went down 0.19%
during the same trading period. The full analyst notes on Sensient
Technologies Corp. are available to download free of charge at:
http://www.AnalystsReview.com/03052014/SXT/report.pdf
--
About Analysts Review
We provide our members with a simple and reliable way to leverage
our economy of scale. Most investors do not have time to track all
publicly traded companies, much less perform an in-depth review and
analysis of the complexities contained in each situation. That's
where Analysts Review comes in. We provide a single unified
platform for investors' to hear about what matters. Situation
alerts, moving events, and upcoming opportunities.
=============
EDITOR NOTES:
- This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
- This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
- If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] AnalystsReview.com.
- For any urgent concerns or inquiries, please contact us
at compliance [at] AnalystsReview.com.
- Are you a public company? Would you like to see similar
coverage on your company? Send us a full investors' package to
research [at] AnalystsReview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort
basis. This document, article or report is prepared and authored by
Analysts Review. An outsourced research services provider
represented by Nidhi Vatsal, CFA, has only reviewed the information
provided by Analysts Review in this article or report according to
the Procedures outlined by Analysts Review. Analysts Review is not
entitled to veto or interfere in the application of such procedures
by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to
the accuracy or completeness or fitness for a purpose (investment
or otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Analysts Review
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Analysts Review expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Analysts Review does not (1)
guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Analysts Review